berotek has been researched along with Shock in 2 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, HG | 1 |
| Goeckenjan, G | 1 |
| Meger, C | 1 |
| Müntefering, H | 1 |
| Kisimre, L | 1 |
| Szabó, E | 1 |
2 other studies available for berotek and Shock
| Article | Year |
|---|---|
[The possible maternal risk of tocolytic therapy with fenoterol (partusisten) (author's transl)].
Topics: Adult; Autopsy; Ethanolamines; Female; Fenoterol; Humans; Myocarditis; Obstetric Labor, Premature; P | 1977 |
[Surgical and conservative treatment of puerperal uterine inversion].
Topics: Adult; Female; Fenoterol; Humans; Injections, Intravenous; Obstetric Labor Complications; Parity; Pr | 1986 |